1tkx: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="1tkx" size="450" color="white" frame="true" align="right" spinBox="true" caption="1tkx, resolution 2.85Å" /> '''CRYSTAL STRUCTURE O...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1tkx.gif|left|200px]]<br />
[[Image:1tkx.gif|left|200px]]<br /><applet load="1tkx" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1tkx" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1tkx, resolution 2.85&Aring;" />
caption="1tkx, resolution 2.85&Aring;" />
'''CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745'''<br />
'''CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745'''<br />


==Overview==
==Overview==
HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs) are part of, the combination therapy currently used to treat HIV infection. The, features of a new NNRTI drug for HIV treatment must include selective, potent activity against both wild-type virus as well as against mutant, virus that have been selected by use of current antiretroviral treatment, regimens. Based on analogy with known HIV-1 NNRTI inhibitors and modeling, studies utilizing the X-ray crystal structure of inhibitors bound in the, HIV-1 RT, a series of substituted 2-quinolones was synthesized and, evaluated as HIV-1 inhibitors.
HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs) are part of the combination therapy currently used to treat HIV infection. The features of a new NNRTI drug for HIV treatment must include selective potent activity against both wild-type virus as well as against mutant virus that have been selected by use of current antiretroviral treatment regimens. Based on analogy with known HIV-1 NNRTI inhibitors and modeling studies utilizing the X-ray crystal structure of inhibitors bound in the HIV-1 RT, a series of substituted 2-quinolones was synthesized and evaluated as HIV-1 inhibitors.


==About this Structure==
==About this Structure==
1TKX is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1] with GWB as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/RNA-directed_DNA_polymerase RNA-directed DNA polymerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.7.49 2.7.7.49] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1TKX OCA].  
1TKX is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1] with <scene name='pdbligand=GWB:'>GWB</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/RNA-directed_DNA_polymerase RNA-directed DNA polymerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.7.49 2.7.7.49] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1TKX OCA].  


==Reference==
==Reference==
Line 15: Line 14:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: RNA-directed DNA polymerase]]
[[Category: RNA-directed DNA polymerase]]
[[Category: Hopkins, A.L.]]
[[Category: Hopkins, A L.]]
[[Category: Ren, J.]]
[[Category: Ren, J.]]
[[Category: Stammers, D.K.]]
[[Category: Stammers, D K.]]
[[Category: Stuart, D.I.]]
[[Category: Stuart, D I.]]
[[Category: GWB]]
[[Category: GWB]]
[[Category: aids]]
[[Category: aids]]
Line 26: Line 25:
[[Category: nnrti]]
[[Category: nnrti]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Thu Nov  8 14:31:21 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:14:39 2008''